Zou Li-ying, Fan Ling, Duan Tao, Wang Zi-lian, Ma Run-mei
Department of Obstetrics, Beijing Obstetrics and Gynecology Hospital, Capital Medical University, Beijing, China.
Zhonghua Fu Chan Ke Za Zhi. 2010 Jul;45(7):492-6.
To investigate safety and efficacy of dinoprostone suppositories (0.8 mm) used in cervical ripening and labor induction in women with term premature rupture of the membranes.
One hundred women of term monocyesis with premature rupture of the membranes, head presentation, bishop score less than 6 (test group) and 180 women with intact fetal membranes (control group) were enrolled into this multicenter, prospective clinical study. The vaginal delivery system was inserted into the posterior fornix, and the patients were recumbent for 2 hours after insertion. The interval time from using dinoprostone suppositories to uterine contraction, to labor and delivery were recorded. The following index were also recorded and compared, including the mean inserted time of dinoprostone suppositories, fetal heart beat, meconium stained amniotic fluid, hyperstimulation of uterus and the other complications, mode of delivery, stage of labor, postpartum hemorrhage, status of neonates.
Three cases in test group and 23 cases in control group weren't in labor within 24 hours. The rate of labor within 24 hours in test group was significant higher than that in control group (97.0% vs. 87.2%, P < 0.01). It was observed that 73 cases undergoing vaginal deliveries (75.3%, 73/97) and 24 cases undergoing cesarean section deliveries (24.7%, 24/97)in test group and 107 cases undergoing vaginal delivery (68.2%, 107/157) and 50 cases undergoing cesarean section delivery (31.8%, 50/157) in control group, when compared the rate of vaginal or cesarean section deliveries between two group, it didn't reach statistical difference (P > 0.05). It had no significant difference in the interval time from using dinoprostone suppositories to labor starting and the mean inserted time and the total labor time between two groups (P > 0.05). The incidence of uterine tachysystole was 11.3% (11/97) in test group and 19.1% (30/157) in control group (P > 0.05), which did not reach statistical difference (P > 0.05). There wasn't neonatal asphyxia in both groups.
It was safe and efficient to use dinoprostone suppositories for cervical ripening and induction of term pregnancy with premature rupture of the membranes, however, monitoring should be intensified.
探讨地诺前列酮栓(0.8mm)用于足月胎膜早破孕妇促宫颈成熟及引产的安全性和有效性。
选取100例足月单胎胎膜早破、头先露、bishop评分小于6分的孕妇(试验组)和180例胎膜完整的孕妇(对照组)纳入本多中心、前瞻性临床研究。将阴道给药系统置入阴道后穹窿,置入后患者卧床2小时。记录使用地诺前列酮栓至子宫收缩、临产及分娩的间隔时间。同时记录并比较以下指标,包括地诺前列酮栓的平均置入时间、胎心、羊水粪染、子宫过度刺激及其他并发症、分娩方式、产程、产后出血、新生儿情况。
试验组3例和对照组23例在24小时内未临产。试验组24小时内临产率显著高于对照组(97.0%对87.2%,P<0.01)。试验组有73例经阴道分娩(75.3%,73/97),24例剖宫产分娩(24.7%,24/97);对照组有107例经阴道分娩(68.2%,107/157),50例剖宫产分娩(31.8%,50/157)。两组阴道分娩或剖宫产分娩率比较,差异无统计学意义(P>0.05)。两组使用地诺前列酮栓至临产开始的间隔时间、平均置入时间及总产程比较,差异无统计学意义(P>0.05)。试验组子宫收缩过速发生率为11.3%(11/97),对照组为19.1%(30/157),差异无统计学意义(P>0.05)。两组均无新生儿窒息发生。
地诺前列酮栓用于足月胎膜早破孕妇促宫颈成熟及引产安全有效,但需加强监测。